7 August 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Ofatumumab results published
A potential new disease modifying drug (DMD) for relapsing remitting MS reduced relapses by a little over half compared to another DMD (Aubagio), according to newly published results. Ofatumumab also reduced disability worsening at three and six months and disease activity on MRI scans
MS Trust link: Ofatumumab (Arzerra)
Nerve protecting mechanism identified
Researchers in Edinburgh have identified a natural mechanism that protects myelin from damage. Research in mice has found that this can be enhance using a diabetes drug called pioglitazone, which may protect nerves from further damage. More trials will be needed to establish how this might work in humans
MS Trust link: Neuroprotection
Natalie's MS journey and how it led to the Black MS Foundation, by Natalie
18 Jan 2022 - 00:00
We caught up with Natalie, Founder of the Black MS Foundation to hear about her multiple sclerosis journey and find out what led her to set up the Foundation.
MS and exercise: part one - a Q&A with physiotherapist, Henriette
14 Jan 2022 - 00:00
In this first blog in a new series, we talk to physiotherapist, Henriette who answers some common questions people with MS may have about exercising.
New study provides strong evidence for role of Epstein Barr virus as a trigger for multiple sclerosis
14 Jan 2022 - 00:00
New research has provided evidence that infection with the Epstein Barr virus acts as a trigger for people to develop MS.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.